Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy.
about
Complications from Stereotactic Body Radiotherapy for Lung CancerAdvances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy.Axitinib Improves Radiotherapy in Murine Xenograft Lung Tumors.Do angiotensin-converting enzyme inhibitors reduce the risk of symptomatic radiation pneumonitis in patients with non-small cell lung cancer after definitive radiation therapy? Analysis of a single-institution databaseFunctional polymorphisms of base excision repair genes XRCC1 and APEX1 predict risk of radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.Genetic variants of the nonhomologous end joining gene LIG4 and severe radiation pneumonitis in nonsmall cell lung cancer patients treated with definitive radiotherapy.Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy.Nondosimetric risk factors for radiation-induced lung toxicity.Soy isoflavones radiosensitize lung cancer while mitigating normal tissue injuryRadiation damage to the lung: mitigation by angiotensin-converting enzyme (ACE) inhibitorsPolymorphisms of the vascular endothelial growth factor gene and severe radiation pneumonitis in non-small cell lung cancer patients treated with definitive radiotherapyInterstitial Lung Change in Pre-radiation Therapy Computed Tomography Is a Risk Factor for Severe Radiation Pneumonitis.Functional dosimetric metrics for predicting radiation-induced lung injury in non-small cell lung cancer patients treated with chemoradiotherapy.Analysis of radiation pneumonitis risk using a generalized Lyman model.Comparison of clinical, tumour-related and dosimetric factors in grade 0-1, grade 2 and grade 3 radiation pneumonitis after stereotactic body radiotherapy for lung tumours.Incorporating single-nucleotide polymorphisms into the Lyman model to improve prediction of radiation pneumonitis.Health behaviors, readiness to change, and interest in health promotion programs among smokers with lung cancer and their family members: a pilot study.A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis.[18F]-FDG uptake dose-response correlates with radiation pneumonitis in lung cancer patients.Poor baseline pulmonary function may not increase the risk of radiation-induced lung toxicity.Differential effect of soy isoflavones in enhancing high intensity radiotherapy and protecting lung tissue in a pre-clinical model of lung carcinoma.Use of 4-dimensional computed tomography-based ventilation imaging to correlate lung dose and function with clinical outcomes.Proton beam therapy for locally advanced lung cancer: A review.Intensity-Modulated Radiotherapy versus 3-Dimensional Conformal Radiotherapy Strategies for Locally Advanced Non-Small-Cell Lung Cancer.Dose-volume histogram parameters for predicting radiation pneumonitis using receiver operating characteristic curve.Radiotherapy for esophageal cancer using simultaneous integrated boost techniques: dosimetric comparison of helical TomoTherapy, Volumetric-modulated Arc Therapy (RapidArc) and dynamic intensity-modulated radiotherapy.Predictors of grade ≥ 2 and grade ≥ 3 radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with three-dimensional conformal radiotherapy.[Predictive marker for acute normal tissue toxity in radiotherapy of non-small cell lung cancer].Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer.Smoking habits of radiotherapy patients: did the diagnosis of cancer make an impact and is there an opportunity to intervene?Occurrence of pneumonitis following radiotherapy of breast cancer - A prospective study.A retrospective study of shrinking field radiation therapy during chemoradiotherapy in stage III non-small cell lung cancer.Preexisting radiological interstitial lung abnormalities are a risk factor for severe radiation pneumonitis in patients with small-cell lung cancer after thoracic radiation therapy.Abnormal pulmonary function tests predict the development of radiation-induced pneumonitis in advanced non-small cell lung Cancer.
P2860
Q26995851-E10A9FEF-8E54-4CE2-8B95-A58454FE1F4DQ33645619-A0512787-E1CD-4BDD-AFBC-B1F82AC3E3ACQ34092023-CD4E3FE1-5875-44EC-AACB-2186DE1DE69CQ34170294-0DC47BEF-6420-483E-850A-86236B835186Q35106036-9218A318-9EBF-4561-8D02-C286081C29CEQ35250155-129B22EA-5686-46FC-B09D-E98F8D25347EQ35273018-17A2639A-B479-41D9-8373-D416BD57A1CBQ35456001-C0433C25-2C2B-48D8-9245-FEF1B7DFA640Q35588229-9C1B052E-197D-4835-B5D2-315F17F2A348Q35631661-CC72DAB1-0D6A-464C-8C9B-F2CE55111656Q35914668-D94ABFC4-2FB2-47F5-995A-E88C12936FDBQ36187134-EE0B1427-524E-4966-8F49-7F1651E5FE47Q36209569-7C28D248-2884-4BEA-9183-0496D70C91F2Q36235629-E13749C5-1F91-4C4E-A296-8374456F4C51Q36343856-035E2763-F80B-4C45-AA3D-A78075810371Q36465589-CE9643E1-88C1-4D64-AD16-EBB1D4B9E27AQ36509544-1DBAB28F-26A0-437E-B5CB-AF5DF81D8EBDQ36569090-CC8831E0-34E7-4F87-8C12-42CF19CB4B28Q36766549-3178FEFB-CE79-4565-8980-0169B1F282ECQ36821497-BFAF59A7-24DC-4928-A7A6-FDA377722CF8Q37341807-460F83C4-BDD1-480D-83DA-E1C1AFCE0679Q37419489-250EE1E3-2E1B-4C0F-A772-47F1C33FC926Q38258751-FFAE634D-7561-40FC-B1C8-173EE991A5CBQ38350598-F2BC94FF-4A69-4F70-A808-199C2A2F665FQ44219216-8A0FAC35-A3BA-4F16-A3A1-DDDDF2A60504Q45899297-710B97A7-0B8F-4204-8E84-407B5EC91384Q46014428-A4B61248-DFA6-4B45-8235-64CB43222DC4Q46095015-4B91B152-9FEF-4D88-BC91-FA83CDB739A0Q47887111-42ECDF8C-E228-4245-9C21-7CD3AD96C440Q48034966-6F3E4795-C84E-4067-8DA9-123B36E54541Q49950515-EDE0FF4E-69B7-467D-AB82-B2824904F93EQ52649579-18EE4E46-5625-41EF-93DC-46150DC637B2Q55079973-AA016FDC-8064-48F2-9817-4509D113C547Q55085494-49B1F72F-597C-49CD-85F7-E3194B0C3E04
P2860
Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Dose-volume thresholds and smo ...... with definitive radiotherapy.
@en
type
label
Dose-volume thresholds and smo ...... with definitive radiotherapy.
@en
prefLabel
Dose-volume thresholds and smo ...... with definitive radiotherapy.
@en
P2093
P2860
P50
P1476
Dose-volume thresholds and smo ...... with definitive radiotherapy.
@en
P2093
Hui Helen Liu
James D Cox
Mary K Martel
Shulian Wang
Susan L Tucker
Yuhchyau Chen
Zhongxing Liao
P2860
P304
P356
10.1016/J.RADONC.2008.09.009
P577
2008-10-18T00:00:00Z